Organigram Global Inc. (TSX:OGI)
1.320
-0.050 (-3.65%)
Oct 30, 2026, 4:00 PM EDT
Organigram Global Market Cap
Organigram Global has a market cap or net worth of CAD 186.13 million as of October 30, 2026. It is the 22,926th most valuable company in the world and the 592nd biggest in Canada. Its market cap has decreased by 38.14% in one year.
Market Cap
186.13M
Enterprise Value
277.17M
Revenue
309.18M
Global Rank
Country Rank
#592 Canada
PE Ratio
2.08
ChartMarket Cap Chart
Since August 26, 2014, Organigram Global's market cap has increased from 103.20M to 186.13M, an increase of 80.35%. That is a compound annual growth rate of 4.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 186.13M | -40.32% |
| Dec 31, 2025 | 311.86M | 7.48% |
| Dec 31, 2024 | 290.16M | 107.85% |
| Dec 29, 2023 | 139.60M | -59.57% |
| Dec 30, 2022 | 345.24M | -49.95% |
| Dec 31, 2021 | 689.84M | 75.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aurora Cannabis | 378.03M |
| Cipher Pharmaceuticals | 345.90M |
| Cresco Labs | 319.03M |
| TerrAscend | 213.33M |
| Cannara Biotech | 198.42M |
| Cardiol Therapeutics | 196.26M |
| BioSyent | 190.55M |
| Medexus Pharmaceuticals | 158.70M |